AU7558787A - Improvements in or relating to organic compounds - Google Patents

Improvements in or relating to organic compounds

Info

Publication number
AU7558787A
AU7558787A AU75587/87A AU7558787A AU7558787A AU 7558787 A AU7558787 A AU 7558787A AU 75587/87 A AU75587/87 A AU 75587/87A AU 7558787 A AU7558787 A AU 7558787A AU 7558787 A AU7558787 A AU 7558787A
Authority
AU
Australia
Prior art keywords
relating
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU75587/87A
Other versions
AU602154B2 (en
Inventor
Peter Hiestand
Douglas Larson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU7558787A publication Critical patent/AU7558787A/en
Application granted granted Critical
Publication of AU602154B2 publication Critical patent/AU602154B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU75587/87A 1986-07-14 1987-07-13 Improvements in or relating to organic compounds Ceased AU602154B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88511086A 1986-07-14 1986-07-14
US885110 1986-07-14

Publications (2)

Publication Number Publication Date
AU7558787A true AU7558787A (en) 1988-01-21
AU602154B2 AU602154B2 (en) 1990-10-04

Family

ID=25386156

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75587/87A Ceased AU602154B2 (en) 1986-07-14 1987-07-13 Improvements in or relating to organic compounds

Country Status (13)

Country Link
JP (1) JPS6323817A (en)
KR (1) KR880001292A (en)
AU (1) AU602154B2 (en)
CH (1) CH672987A5 (en)
DE (1) DE3722383A1 (en)
DK (1) DK363887A (en)
FR (1) FR2601245A1 (en)
GB (1) GB2192541B (en)
IT (1) IT1224222B (en)
NL (1) NL8701631A (en)
PH (1) PH24525A (en)
SE (1) SE8702843L (en)
ZA (1) ZA875145B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU622614B2 (en) * 1987-05-07 1992-04-16 Peter S. Mueller Improvements in or relating to organic compounds

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0327040A3 (en) * 1988-02-05 1990-11-28 Predrag Dr.Sc. Sikiric Use of dopamine and/or dopamine agonists to prepare a medicine for the treatment of the digestive tract
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5585347A (en) * 1988-05-10 1996-12-17 Ergo Science Incorporated Methods for the determination and adjustment of prolactin daily rhythms
US5716933A (en) * 1988-05-10 1998-02-10 Louisiana State University And Agricultural And Mechanical College Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US5830895A (en) * 1988-05-10 1998-11-03 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods for the determination and adjustment of prolactin daily rhythms
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
US5744477A (en) * 1988-05-10 1998-04-28 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for treatment of obesity using prolactin modulators and diet
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
RU2104698C1 (en) * 1991-12-23 1998-02-20 Дзе Борд оф Сьюпервайзорз оф Луизиана Стейт Юниверсити энд Эгрикалчурал энд Мекэникал Колледж Method of treatment of pathological deviations at diabetes mellitus of type-2
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5714519A (en) * 1995-06-07 1998-02-03 Ergo Science Incorporated Method for regulating glucose metabolism
US5626860A (en) * 1995-06-07 1997-05-06 The Board Of Supervisors Of Louisana State And Agricultural And Mechanical College Method for regulating metabolism with dopamine beta hydroxylase inhibitors
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
ES2425581T3 (en) 2006-11-23 2013-10-16 Sinoxa Pharma Gmbh Pharmaceutical compositions for the treatment of capillary artery disease
EP3925610A1 (en) * 2016-04-20 2021-12-22 VeroScience LLC Composition and method for treating metabolic disorders
EP3697418A4 (en) 2017-10-18 2021-07-14 VeroScience LLC Improved bromocriptine formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (en) * 1968-05-31 1971-05-15 Sandoz Ag Process for the preparation of 2-bromo-a-ergocryptine
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (en) * 1984-02-29 1988-07-29 Sandoz Ag METHOD FOR PRODUCING microcapsules BROMOKRIPTINMESYLAT AS PHARMACOLOGICAL ACTIVE INCLUDED.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU622614B2 (en) * 1987-05-07 1992-04-16 Peter S. Mueller Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
GB2192541B (en) 1990-05-02
FR2601245A1 (en) 1988-01-15
SE8702843L (en) 1988-01-15
KR880001292A (en) 1988-04-22
DK363887D0 (en) 1987-07-13
JPS6323817A (en) 1988-02-01
IT8748160A0 (en) 1987-07-10
DK363887A (en) 1988-01-15
SE8702843D0 (en) 1987-07-13
GB8716323D0 (en) 1987-08-19
GB2192541A (en) 1988-01-20
IT1224222B (en) 1990-09-26
CH672987A5 (en) 1990-01-31
AU602154B2 (en) 1990-10-04
DE3722383A1 (en) 1988-01-28
NL8701631A (en) 1988-02-01
ZA875145B (en) 1989-02-22
PH24525A (en) 1990-07-18

Similar Documents

Publication Publication Date Title
AU1892088A (en) Improvements in or relating to organic compounds
AU2490288A (en) Improvements in or relating to organic compounds
AU4140089A (en) Improvements in or relating to organic compounds
AU4587189A (en) Improvements in or relating to organic compounds
AU3263789A (en) Improvements in or relating to organic compounds
GB2203163B (en) Improvements in or relating to organic compounds
AU7558787A (en) Improvements in or relating to organic compounds
AU1889388A (en) Improvements in or relating to organic compounds
AU2417588A (en) Improvements in or relating to organic compounds
AU5763786A (en) Improvements in or relating to organic compounds
GB9007514D0 (en) Improvements in or relating to organic compounds
AU1840988A (en) Improvements in or relating to organic compounds
AU3901789A (en) Improvements in or relating to organic compounds
AU5931386A (en) Improvements in or relating to organic compounds
AU3131389A (en) Improvements in or relating to organic compounds
AU8057587A (en) Improvements in or relating to organic compounds
AU6314090A (en) Improvements in or relating to organic compounds
AU4453589A (en) Improvements in or relating to organic compounds
AU5060190A (en) Improvements in or relating to organic compounds
AU586621B2 (en) Improvements in or relating to organic compounds
AU5379286A (en) Improvements in or relating to organic compounds
AU1560588A (en) Improvements in or relating to organic compounds
AU7932587A (en) Improvements in or relating to organic compounds
AU7525987A (en) Improvements in or relating to organic compounds
AU4616189A (en) Improvements in or relating to organic compounds